[Hemopoietic cells from human embryonic liver in the treatment of HIV/AIDS].
Transplantation of human fetal liver cells is used for the deficient cellular mediators and humoral immunological factors to be efficiently replenished through proliferation and differentiation of embryonic stem cells contained in cellular suspensions. Kept under hospital observation were 17 patients: two female patients aged 24 and 40 years respectively and 15 male patients with a mean age of 35 years. There were no instances of intolerance, side effects, graft-versus-host reaction. Informed consent was elicited from the patients to performing grafting.
Pylypchak
O M
OM
D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology / Q000628:therapy*; D000328:Adult; D005260:Female; D016332:Fetal Tissue Transplantation; D015658:HIV Infections / Q000276:immunology / Q000628:therapy*; D015497:HIV-1; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007111:Immunity, Cellular; D008099:Liver / Q000196:embryology*; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged